Protein chemical analysis of amyloid beta-protein in the brain of early stages of beta-amyloidogenesis
β-淀粉样蛋白生成早期大脑中淀粉样β-蛋白的蛋白质化学分析
基本信息
- 批准号:09835003
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. We have examined amyloid beta-protein (Abeta) deposition in many autopsied human brains using two-site ELISA and immunocytochemistry, and found that Abeta accumulates in the brain during normal aging. The level of Abeta in the brain correlated well with the abundance of senile plaque. In addition, Abeta accumulation which could be detected by ELISA preceded immunocytochemically detectable Abeta deposition in the brain.2. The present ELISA system captured SDS-dissociable A13 but not SDS-stable Abeta dimer. Western blot analysis of the brains in which the level of Abeta was below the detection limit of ELISA showed that many of such specimens contained SDS-stable Abeta dimer, but not SDS-dissociable Abeta monomer. The results indicate that SDS-stable Abeta dimer accumulates in the brain at the very initial stages, raising a possibility that SDS-stable dimer plays important roles in beta-amyloidogenesis in the aged human brain and the neurodegeneration of AD.3. Fractionation of the deposited Abeta species in normal aged brains by CsCl isopycnic density gradient centrifugation showed that a part of the Abeta was fractionated into the low-density membrane fraction. From analyses of their electrophoretic mobilities and reactivities with various Abeta antibodies, however, these Abeta molecules were not likely to be the same as GM1 ganglioside-bound Abeta found in the Down's syndrome brains.4. We have shown that intracellular A13 is present in the insoluble fractions as well as in the soluble fractions of human neuroblastoma cells. The insoluble fraction appeared to contain also SDS-stable Abeta dimer. Approximately half an amount of the insoluble Abeta was associated with caveolae-like low-density membrane domains. Fractionation of the homogenates from normal aged brains by the same procedure revealed that a substantial proportion of Abeta is localized in the low-density membrane domains.
1. 我们使用双位点ELISA和免疫细胞化学检测了许多尸检人脑中的淀粉样β蛋白(Abeta)沉积,发现在正常衰老过程中,Abeta在大脑中积累。大脑中β的水平与老年斑的丰度密切相关。此外,ELISA检测到的Abeta积累先于免疫细胞化学检测到的Abeta在脑内的沉积。本ELISA系统可捕获sds可解离的A13,但不能捕获sds稳定的β二聚体。对Abeta水平低于ELISA检测限的脑组织进行Western blot分析,发现许多样品含有sds稳定的Abeta二聚体,但不含sds可解离的Abeta单体。结果表明,sds稳定的β二聚体在大脑的初始阶段就积累了,这可能表明sds稳定二聚体在老年人脑的β -淀粉样蛋白形成和ad的神经变性中起重要作用。用CsCl等密度梯度离心对正常老年脑组织中沉积的Abeta进行分离,发现部分Abeta被分离成低密度膜组分。然而,从它们的电泳流动性和与各种β抗体的反应性分析来看,这些β分子不太可能与唐氏综合症患者大脑中发现的GM1神经节苷脂结合的β分子相同。我们已经证明,细胞内A13存在于人类神经母细胞瘤细胞的不可溶部分和可溶部分。不溶部分似乎也含有sds稳定的β二聚体。大约一半的不溶性β与小泡样低密度膜结构域有关。用同样的方法从正常衰老的大脑中分离匀浆,发现相当大比例的β定位在低密度的膜域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Oyama F.: "Mutant presenilin 2 transgenic mouse : effect on an age-dependent increase of amyloid β-protein 42 in the brain." J.Neurochem.71. 313-322 (1998)
Oyama F.:“突变早老素 2 转基因小鼠:对大脑中淀粉样蛋白 42 的年龄依赖性增加的影响。J.Neurochem.71 (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shinkai Y., et al.: "Amyloid beta-protein deposition in the leptomeninges and cerebral cortex." Ann.Neurol.42. 899-908 (1997)
Shinkai Y. 等人:“淀粉样 β 蛋白沉积在软脑膜和大脑皮层中。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakabayashi J., et al.: "Amyloid beta-protein (Abeta) accumulation in the putamen and mammillary body during aging and in Alzheimer disease." J.Neuropathol.Exp.Neurol.57. 343-352 (1998)
Nakabayashi J. 等人:“在衰老过程中和阿尔茨海默病中,淀粉样β蛋白 (Abeta) 在壳核和乳头体中积累。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Morishima-Kawashima M.: "The presence of amyloid β-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells." Biochemistry. 37・44. 15247-15253 (1998)
Morishima-Kawashima M.:“人类神经母细胞瘤细胞的去污剂不溶性膜室中存在淀粉样蛋白。” 37・44(1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Enya M.: "Appearance of sodium dodecyl sulfate-stable amyloid β-protein (Aβ) dimer in the cortex during aging." Am.J.Pathol.154・1. 271-279 (1999)
Enya M.:“衰老过程中皮质中十二烷基硫酸钠稳定的淀粉样蛋白 (Aβ) 二聚体的出现。”Am.J.Pathol.154·1 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORISHIMA Maho其他文献
MORISHIMA Maho的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORISHIMA Maho', 18)}}的其他基金
Characterization of gamma-secretase activity in the brain and its significance in the development of Alzheimer's disease
大脑中γ-分泌酶活性的特征及其在阿尔茨海默病发展中的意义
- 批准号:
24500433 - 财政年份:2012
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Amyloid β-protein production and metabolism of intramembrane regin of APPthrough stepwise processing.
β淀粉样蛋白的产生和APP膜内区域的代谢通过逐步加工。
- 批准号:
18500277 - 财政年份:2006
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of γ-cleavage for the generation of amyloid β-protein
γ-裂解产生β-淀粉样蛋白的分子机制
- 批准号:
14580737 - 财政年份:2002
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
- 批准号:
2904538 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Studentship
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
- 批准号:
24K18602 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
- 批准号:
MR/Y004116/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
- 批准号:
2347698 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Continuing Grant
Development of novel macrocyclic BACE1 inhibitors for preventive or therapeutic agents for Alzheimer's disease
开发用于预防或治疗阿尔茨海默病的新型大环 BACE1 抑制剂
- 批准号:
23K06058 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Incorporating Diversity in Alzheimer's Disease Research: Developing Representative and Generalizable models
将多样性纳入阿尔茨海默病研究:开发代表性和可推广的模型
- 批准号:
495662 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Histone variant macroH2A1 as a novel regulator of memory deficits in Alzheimer's disease
组蛋白变体 MacroH2A1 作为阿尔茨海默病记忆缺陷的新型调节剂
- 批准号:
478226 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Investigation of treatment and prevention methods for Alzheimer's disease targeting orexin neurons
针对食欲素神经元的阿尔茨海默病治疗和预防方法的研究
- 批准号:
23K14364 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of testosterone signaling in microglia: a potential role for sex differences in Alzheimer's Disease
睾酮信号在小胶质细胞中的作用:性别差异在阿尔茨海默病中的潜在作用
- 批准号:
23KJ1699 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Targeting Circadian Clock Dysfunction in Alzheimer's Disease (TClock4AD)
针对阿尔茨海默氏病的生物钟功能障碍 (TClock4AD)
- 批准号:
EP/X030091/1 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant














{{item.name}}会员




